In an extensive cohort study of patients with type 2 diabetes, use of GLP-1 receptor agonists was associated with a significantly higher risk for GERD compared to SGLT-2 inhibitors.
Most Recent Articles
A Network Meta-Analysis of 42 Systemic Treatments for Chronic Urticaria
A landmark network meta-analysis of 93 studies has identified the most effective and safest systemic treatments for patients with chronic hives refractory to antihistamines.
AI-Driven Echocardiogram Interpretation: Multisite Validation of the PanEcho System
A new AI model called PanEcho can automatically interpret complete echocardiograms with high accuracy, potentially accelerating workflows and enabling rapid cardiovascular screening in point-of-care settings.
Efficacy of Baxdrostat in Primary Aldosteronism: Findings from the SPARK Phase 2a Trial
A new drug called baxdrostat shows transformative potential for treating a common but under-diagnosed cause of high blood pressure by significantly lowering blood pressure and normalizing key hormone levels.
Successful Use of Ruxolitinib in a Case of Acute Fulminant Myocarditis
UC San Francisco researchers report a breakthrough case where a JAK inhibitor successfully treated a patient with life-threatening acute fulminant myocarditis, a severe form of heart inflammation.